Image of hexagons overlapping in different sizes

Application of ICH Q2/Q14 to Procedure Development and Changes for Monoclonal Antibodies and Gene Therapy Products

Home / Papers and Presentations / Resource
CMC Strategy Forum Europe
Speaker Presentation CMC Europe 2024
Chéry Cyrille, UCB Pharma S.A., 2024
Application of ICH Q2/Q14 to Procedure Development and Changes for Monoclonal Antibodies and Gene Therapy Products

Related Files